Biotherapy for antibiotic-associated and other diarrhoeas

Journal of Infection

Volumn 32, Issue 1, 1996, Pages 1-10

  Roffe, Christine ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; YOGHURT;

BACTERIAL GROWTH; BACTERIUM; CLOSTRIDIUM DIFFICILE; DIARRHEA; FERMENTATION; HUMAN; INTESTINE FLORA; MILK; REVIEW; YEAST;

EID: 0029875182     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(96)80002-8     Document Type: Review

References (61)

1. Metchnikov E. The prolongation of life. New York: G. P. Putnam's Sons. 1908: 161-183.
2. George RH, Symonds JM, Dimock F et al. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J 1978; i: 695.
3. Larson HE, Price HB, Honour P, Borriello SP. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978; 1: 1063-1066.
4. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. J Am Med Assoc 1993; 269: 71-75.
5. Wilkins E. Tres difficile. J Infect 1993; 26: 1-7.
6. Cudmore MR, Silva J Jr, Fekety R, Liepman MK, Kim K-H. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med 1982; 142: 333-335.
7. Cuzzolin L, Zambreri D, Donini M, Griso C, Benoni G. Influence of radiotherapy on intestinal microflora in cancer patients. J Chemother 1992; 4: 176-179.
8. Borriello SP. The influence of normal flora on Clostridium difficile colonization of the gut. Ann Med 1990; 22: 61-67.
9. Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56: 2610-2614.
10. Rolfe RD. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect Immun 1984; 45: 185-191.
11. Krämer J, Brandis H. Purification and characterization of two bacteriocins from Streptococcus faecium. J Gen Microbiol 1975; 88: 93-100.
12. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-581.
13. Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant salmonella from animals fed antimicrobials. N Engl J Med 1984; 311: 617-622.
14. Borriello SP, Larson HE, Welch AR. Enterotoxigenic Clostridium perfringens: a possible cause for antibiotic-associated diarrhoea. Lancet 1984; i: 305.
15. Eisemann B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859.
16. Carter AO, Borczyk AA, Carlson JA et al. A severe outbreak of Escherichia coli O157:H7-associated haemorrhagic colitis in a nursing home. N Engl J Med 1987; 317: 1496-1500.
17. Danna PL, Urban C, Bellin E, Rahal JJ. Role of Candida in the pathogenesis of antibiotic-associated diarrhoea in elderly patients. Lancet 1991; 337: 511-514.
18. Borriello P, Hudson M, Hill M. Investigation of the gastrointestinal bacterial flora. Clin Gastroenterol 1978; 7: 329-349.
19. Bergogne-Brezin E. La flore intestinale. La Gazette Medicale 1993; 100: 19-22.
20. Wilcox HM, Spencer RC. Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 1992; 22: 85-92.
21. Pothoulakis C, Castagliuolo I, Kelly CP, LaMont T. Clostridium difficile associated diarrhea and colitis: pathogenesis and therapy. Int J Antimicrob Agents 1993; 3: 17-32.
22. Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranus colitis. Gastroenterol 1980; 78: 431-434.
23. Johnson S, Adelmann A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism. J Infect Dis 1989; 159: 340-343.
24. O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 1991; 107: 627-635.
25. Siitonen S, Vapaatalo H, Salminen S et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 57-59.
26. Lewenstein A, Frigerio G, Moroni M. Biological properties of SF 68. A new approach for the treatment of diarrhoeal diseases. Curr Therap Res 1979; 26: 967-981.
27. Mitra AK, Rabbani GH. A double-blind controlled trial of Bioflorin (Streptococcus faecium SF 68) in adults with acute diarrhea due to enterotoxigenic Vibrio cholerae and Escherichia coli. Gastroenterol 1990; 99: 1149-1152.
28. Seal D, Borriello SP, Barclay F, Welch A, Piper M, Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Microbiol 1987; 6: 51-53.
29. McFarland LV, Bernasconi P. Saccharomyces boulardii: a review of an innovative biotherapeutic agent. Microb Ecol Hlth Dis 1993; 6: 157-171.
30. Blehaut H, Masssot J, Elmer GW, Levy RH. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 1989; 10: 353-364.
31. Schellenberg D, Bonington A, Champion CM, Lancaster R, Webb S, Main J. Treatment of Clostridium difficile diarrhoea with brewer's yeast. Lancet 1994; 343: 171-172.
32. Adam J, Barret A, Barrett-Bellet C et al. Essais cliniques contrôlés en double insu de l'ultra-levure lyophilisée. Etude multicentrique par 25 médecins de 388 cas. Gazette Médicale Francaise 1977; 84: 2072-2078.
33. Surawicz CM, Elmer GM, Speelman P, McFarland LV, Chinn J. VanBelle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterol 1989; 96: 981-988.
34. Columbel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; ii: 43.
35. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 1979; 36: 754-757.
36. Tankanow RM, Ross MB, Ertel IJ et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. Ann Pharmacotherapy 1990; 24: 382-384.
37. Ligny G. Le traitement par l'ultra-levure des troubles intestinaux secondaires a l'antibiothérapie: étude en double aveugle et étude clinique simple. Revue Française de Gastroenterologie 1975; 114: 45-50.
38. McFarland LV, Surawicz CM, Greenberg RN et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. J Am Med Assoc 1994; 271: 1913-1918.
39. Beck C, Necheles H. Beneficial effects of the administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders. Am J Gastroenterol 1961; 35: 522-530.
40. Settel E. Lactobacillus acidophilus in the treatment of functional gastrointestinal disorders. Clin Med 1962; 69: 700-704.
41. Cano N, Chapoy P, Corthier G. Saccharomyces boulardii: un traitement des colites pseudomembraneuses? Presse Medicale 1989; 18: 1299.
42. Buts J-P, Corthier G, Delmee M. Saccharomyces boulardii for Clostridium difficile associated enteropathies in infants. J Pediatr Gastroenterol Nutr 1993; 16: 419-425.
43. Surawiecz CM, McFarland LV, Elmer G, Chinn J. Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-1287.
44. Kimmey MB, Elmer GW, Surawicz CM, McFarland LV. Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Sci 1990; 35: 897-901.
45. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; ii: 1519.
46. Bowden TA, Mansberger AL, Lykins LE. Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. American Surg 1981; 47: 178-183.
47. Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211-215.
48. Tvede M, Rask-Maden J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; i: 1156-1160.
49. Pozo-Olano J, Warram JH, Gómez RG, Cavasos MG. Effect of a lactobacilli preparation on traveller's diarrhea. Gastroenterol 1978; 74: 820-830.
50. Oksanen PJ, Salminen S, Saxelin M et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 53-56.
51. Saveedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding rotavirus. Lancet 1994; 344: 1046-1049.
52. Tempé JD, Steidel AL, Blehaut H, Hasselmann M, Lutun Ph, Maurier F. Prévention par Saccharomyces boulardii des diarrhées de l'alimentation entérale à débit continu. Sem Hôp Paris 1983; 59: 1409-1412.
53. Schlotterer M, Bernasconi P, Lebreton F, Wasserman D. Value of Saccharomyces boulardii in the digestive acceptability of continuous flow enteral nutrition in burnt patients. Nutr Clin Metabol 1987; 1: 31-34.
54. Clements ML, Levine MM, Black RE et al. Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob Agents Chemother 1981; 20: 104-108.
55. Camarri E, Belvisi A, Guidoni G, Marini G, Frigerio G. A double-blind comparison of two different treatments for acute enteritis in adults. Chemotherapy 1981; 27: 466-470.
56. Höchter W, Chase D, Hagenoff G. Saccharomyces boulardii bei akuter Erwachsenendiarrhoe. Wirksamkeit und Verträglichkeit der Behandlung. Münchner Medizinische Wochenschrift 1990; 132: 188-192.
57. Chapoy P. Traitement des diarrhées aiguës infantiles: essai contrôlé de Saccharomyces boulardii. Annales de Pediatrie (Paris) 1985; 32: 561-563.
58. Cetina-Sauri G, Basto GS. Evaluación therapéutica de Saccharomyces boulardii en niños con diarrea aguda. Tribuna Medica 1989; 56: 111-115.
59. Joirou A, Jeridi A, Ben Saïd H, El Mabrouk J, Essoussi AS, Harbi A. Le traitment de diarrhees aigues du nourisson: place de Saccharomyces boulardii. Maghreb Médical 1990; 229: 29-31.
60. Pearce JL, Hamilton JB. Controlled trial of orally administered lactobacilli in acute infantile diarrhea. J Pediatr 1974; 84: 261-262.
61. Giudici HJ, Bottto L, Montejo de Aramayo IA, Aramayo L. Evaluación clínica de la administración de Saccharomyces boulardii "Vitales" en el tratamiento de la diarrea aguda en niños. Informe preliminar. La Semana Médica 1985; 167: 2254-2262.